Dr TEOH Yuen Chun Jeremy    
張源津

Assistant Professor
MBBS, FRCSEd (Urol), FCSHK, FHKAM (Surgery)

Urology
(852) 3505 2629 / Appointment 3505 2954
jeremyteoh@surgery.cuhk.edu.hk
@jteoh_hk
H-5184-2016
0000-0002-9361-2342

Biography

Dr Jeremy Teoh is currently the Assistant Dean (External Affairs) and Assistant Professor of the Faculty of medicine, The Chinese University of Hong Kong. He has primary interests in bladder cancer and prostate cancer. For bladder cancer, he is leading a multi-centre randomized controlled trial on transurethral en bloc resection of bladder tumour. He has also developed a global consensus statement to standardize the en bloc resection approach. He is currently studying the urinary biomarkers, tumour heterogeneity and molecular classification of bladder cancer. For prostate cancer, he has published extensively on the adverse events related to androgen deprivation therapy. He has also helped conduct a clinical trial on the use of the da Vinci Single-Port Surgical System in radical prostatectomy.

Jeremy has received numerous research grants with a total funding of more than HKD 30 million. He has published more than 100 articles in peer-reviewed journals such as European Urology, Journal of Urology and BJU International. He has been a reviewer for more than 30 journals including Cochrane Urology, European Urology, and British Journal of Urology International. He is an editorial board member for a number of prominent journals, and he has been serving as a member for several advisory boards for prostate cancer and bladder cancer. He is currently the Chairperson of the Younger Fellows Chapter of the College of Surgeons of Hong Kong, the Vice-Chair of the Young Fellows Chapter of the Hong Kong Academy of Medicine, and he has been the Director of the Lions Kidney Educational Centre & Research Foundation since 2016. He is also the founder of the UroSoMe (Urology Social Media) working group and he believes that social media plays an important role in the modern era of medicine.

Research Interests

• Urinary biomarkers for bladder cancer
• Tumour heterogeneity and molecular classification of bladder cancer
• Transurethral en bloc resection of bladder tumour
• Androgen deprivation therapy for prostate cancer
• Advanced robotic surgery for urological cancers

Additional Information

• Assistant Dean (External Affairs), Faculty of Medicine, The Chinese University of Hong Kong
• Member of the Office of Global Engagement, Faculty of Medicine, The Chinese University of Hong Kong
• Member of the Committee on Promotion of Organ Donation, HKSAR
• Council member of the Hong Kong Society of Transplantation
• Director of the Lions Kidney Educational Centre & Research Foundation
• Chairperson of the Younger Fellows Chapter, College of Surgeons of Hong Kong
• Vice-Chair of the Young Fellows Chapter, Hong Kong Academy of Medicine
• Member of the European Association of Urology Young Academic Urologists, Urothelial Cancer Working Party
• Committee Member of the SIU Innovators
• Faculty of the Asian Urological Surgery Training & Education Group
• Founder of the UroSoMe (Urology Social Media) working group
• Social media editor for the SIU journal
• Social media editor for the Hong Kong Medical Journal
• Associate editor for the Frontiers in Surgery
• Editorial board member for BMC Urology
• Academic editor for PLOS ONE

Selected Publications

1. Teoh JY, Huang J, Ko WY, Lok V, Choi P, Ng CF, et al. Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita. Eur Urol 2020. (Impact factor 18.728)
2. Teoh JY, MacLennan S, Chan VW, Miki J, Lee HY, Chiong E, et al. An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting. Eur Urol. 2020. (Impact factor 18.728)
3. Teoh JY, Ong WLK, Gonzalez-Padilla D, Castellani D, Dubin JM, Esperto F, et al. A Global Survey on the Impact of COVID-19 on Urological Services. Eur Urol. 2020. (Impact factor 18.728)
4. Rodriguez Socarrás M, Loeb S, Teoh JY, Ribal MJ, Bloemberg J, Catto J, et al. Telemedicine and Smart Working: Recommendations of the European Association of Urology. Eur Urol 2020. (Impact factor 18.728)
5. Wang G, Choi KS, Teoh JY, Lu J. Deep Cross-Output Knowledge Transfer Using Stacked-Structure Least-Squares Support Vector Machines. IEEE Trans Cybern 2020; PP. (Impact factor 11.079)
6. Wong SH*, Teoh JYC*, Leung CH, Wu WK, Yip BHK, Wong MC, Hui DS. COVID-19 and Public Interest in Face Mask Use. Am J Respir Crit Care Med 2020. *Co-first authors. (Impact factor 17.452)
7. Teoh JY, Leung CH, Wang MH, Chiu PK, Yee CH, Ng CF, et al. The cost-effectiveness of prostate health index for prostate cancer detection in Chinese men. Prostate Cancer Prostatic Dis 2020. (Impact factor 4.311)
8. Fankhauser CD, Teoh JY, Mostafid H. Treatment options and results of adjuvant treatment in nonmuscle-invasive bladder cancer (NMIBC) during the Bacillus Calmette-Guerin shortage. Curr Opin Urol. 2020. (Impact factor 2.084)
9. Chan VW, Chiu PK, Yee CH, Yuan Y, Ng CF, Teoh JY. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions. World J Urol. 2020. (Impact factor 3.217)
10. Teoh JY, Mackenzie G, Smith M, Yuen SK, Gudaru K, Leow JJ, et al. Understanding the Composition of a Successful Tweet in Urology. Eur Urol Focus. 2020;6:450-7. (Impact factor 4.827)

The full list of publications can be accessed here.